Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 173Lymphoma, Non-Hodgkin 155Leukemia, Lymphocytic, Chronic, B-Cell 154Lymphoma, Large B-Cell, Diffuse 134Lymphoma, Follicular 131Lymphoma, Mantle-Cell 93Leukemia 68Lymphoma, B-Cell, Marginal Zone 67Waldenstrom Macroglobulinemia 49Burkitt Lymphoma 43Lymphoma, B-Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Hodgkin Disease 36Recurrence 24Lymphoma, Large-Cell, Immunoblastic 24Neoplasms 15Myelodysplastic Syndromes 15Lymphoma, Large-Cell, Anaplastic 15Multiple Myeloma 13Leukemia, Myeloid, Acute 12Lymphoma, T-Cell, Cutaneous 9Lymphoma, Extranodal NK-T-Cell 9Leukemia, Hairy Cell 9Intraocular Lymphoma 9Hematologic Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Sezary Syndrome 7Mycosis Fungoides 7Lymphoma, T-Cell 7

Interventions

Etoposide 4Cyclophosphamide 4Vincristine 3Specimen Handling 3Prednisone 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Biopsy 3fludarabine phosphate 2cabozantinib 2Whole-Body Irradiation 2Watchful Waiting 2Rituximab 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1prednylidene 1pembrolizumab 1fludarabine 1emvododstat 1efineptakin alfa 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × HIV Infections × Rituximab × Clear all
NCT01193842 2023-11-21

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

National Cancer Institute (NCI)

Phase 1/2 Completed
107 enrolled 24 charts
Lymphoid

Plasmablastic Lymphoma, Lymphoma, Follicular, HIV Infections, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Primary Effusion

NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
194 enrolled 19 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡